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Background: Pancreatic anastomotic leaks are a major cause of morbidity and mortality following
pancreaticoduodenectomy, and no single technique of reconstruction has shown to be superior. The
aim of this study was to review the experience of single loop versus isolated Roux loop pan-
creaticojejunostomy in a series of patients undergoing pancreatic head resection.
Methods: A retrospective review involving 111 patients who underwent pancreatic head resections over
13 year period (1994–2006) for malignant (n ¼ 106) and benign (n ¼ 5) disease was performed. Re-
construction of the pancreatic remnant was done using a single loop in 51 patients and by an isolated
Roux loop in 60 patients. All pancreatic anastomosis were performed as a duct to mucosa anastomosis, in
two layers, with pancreatic stent and closed suction drainage. Pancreatic ﬁstula was deﬁned as drainage
of greater than 50 ml of amylase rich ﬂuid for more than 7 days postoperatively.
Results: The two groups were comparable as regards to their demographic proﬁles, preoperative labo-
ratory values and disease status in terms of pathology, pancreatic texture and pancreatic duct diameters.
The overall incidence of pancreatic anastomotic leak was 11% (12) and was similar in both the groups;
single loop 12% (6) and isolated Roux loop 10% (6). Isolated Roux loop pancreaticojejunostomy was as-
sociated with a signiﬁcant prolongation of operative time (7.25  1.14 h vs 6.07  1.12 h) (p < 0.05) and
the need for more blood transfusion (2.25  0.84 units vs 2.62  0.69 units) (p < 0.05). There was no
signiﬁcant difference in the morbidity or mortality between the two groups. Forty ﬁve percent (23)
patients had complications in the single loop group and 48% (29) patients had complications in the
isolated group. There were 8% (4) death in the single loop group and 8% (5) in the isolated group
(p > 0.05).
Conclusion: There does not appear to be a signiﬁcant difference in the rates of pancreatic ﬁstula
following either method of reconstruction. However, performance of an isolated Roux loop pan-
creaticojejunostomy entails a prolongation of operative time and more intraoperative requirement of
blood transfusions.
 2008 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
The operative mortality following pancreaticoduodenectomy
(PD) has decreased to 4% or less at major centers, but complications
arising from disruption of the pancreatic anastomosis remain
a major source of morbidity.1–7 The incidence of pancreatic anas-
tomotic leak ranges from 5% to 25% in most series when pan-
creaticojejunostomy (PJ) is the method of reconstruction.1–7
Variations in the incidence of pancreatic ﬁstula between centers
may be related to the technique of reconstruction. The concept of
isolated Roux loop pancreaticojejunostomy was ﬁrst described by
Machado et al.8 with an attempt to reduce the activation of: þ91 172 274 4401.
ciates Ltd. Published by Elsevier Ltpancreatic juice by biliary secretion there by reducing the incidence
of anastomotic breakdown. Further studies have described patients
who underwent an isolated Roux loop PJ reconstruction with a low
pancreatic ﬁstula rate and related mortality.9–14
The aim of this studywas to compare the results of isolated Roux
loop PJ with that of single loop PJ with regards to the rate of
occurrence of pancreatic ﬁstula and postoperative morbidity and
mortality.2. Patients and methods
Pancreaticoduodenectomy was performed in 111 patients be-
tween 1994 and 2006 in a single unit at a tertiary care hospital in
North India. The medical records of these patients were reviewed
and all clinical, preoperative, operative and pathologic data wered. All rights reserved.
Fig. 1. Single loop pancreaticojejunostomy.
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of management of the pancreatic remnant, with one group in-
cluding thosewhounderwent a single loop pancreaticojejunostomy
reconstruction and the second group including those who
underwent an isolated Roux loop pancreaticojejunal anastomosis.
Two surgeons (RNK&AB)were exclusively doing isolated Roux loop
PJ and two surgeons (LK & RS) were exclusively doing single loop PJ.
The case volume was four to eight per year per surgeon and was
operating in combination also. The study included 74 men and 37
womenwith amean age of 50.5 years (range 18–78 years) (Table 1).
Preoperatively 40 (78%) and 44 (73%) patients had jaundice in the
single loop and isolated Roux loop group respectively. The bilirubin
level was 8.3  6.2 in the single loop group and 8.08  5.49 in the
isolated Roux loop group. The albumin level was 2.91  0.45 and
2.77  0.32 in the two groups which was statistically not signiﬁcant
(Table 1). A conventional Whipple’s operation was done in 102
patients and nine patients underwent a pylorus preserving pan-
creaticoduodenectomy. A total of 51 patients underwent a single
loop PJ reconstruction while 60 patients received an isolated Roux
loop PJ anastomosis. There was no exclusion and no change in
distribution of type of operation over time.2.1. Surgical technique
Pancreaticoduodenal resection was performed with either the
classic Whipple’s resection or the pylorus preserving modiﬁcation.
All patients were assessed as regards to pancreatic ductal diameter
following resection; following which pancreatic duct stent was
placed using eight French infant feeding tubes (ROMSON, India)
which were externalized. All pancreatic anastomosis were hand
sewn and constructed in two layers; 300 polyglactin (Vicryl; Ethi-
con, Johnson and Johnson, India) for the inner layer mucosa to
mucosa and 300 silk for the outer layer seromuscular to the pan-
creatic capsule and parenchyma in interrupted manner. A feeding
jejunostomy was done in every patient. Octreotide was not used
postoperatively because of the prohibitive cost.
In the group of patients who underwent a single loop PJ re-
construction, the retained jejunum was brought through a rent in
the right transverse mesocolon with the PJ anastomosis performed
ﬁrst, to the side of the jejunum, following sequentially by a stan-
dard end to side hepaticojejunostomy and gastrojejunostomy or
duodenojejunostomy (Fig. 1).
In those who received an isolated Roux loop PJ anastomosis,
reconstruction was begun using the transected jejunum, broughtTable 1
Demographic proﬁle and preoperative data (n ¼ 111) showing number and per-
centage with mean standard deviation
Single loop (n ¼ 51) Isolated loop (n ¼ 60) p-value
Age (years) 50  13.6 51  13.3 NS
Sex
Male 35 (68.6%) 39 (65%) NS
Female 16 (31.3%) 21 (35%) NS
Preoperative data
Jaundice 40 (78%) 44 (73%) NS
Weight loss 22 (43%) 29 (48%) NS
Abdominal pain 31 (62%) 33 (55%) NS
Diabetes 10 (20%) 14 (23%) NS
Cholangitis 9 (18%) 9 (15%) NS
Preop. biliary drainage 10 (20%) 8 (13%) NS
Preop. lab values
Hemoglobin (gm %) 10  1.65 9.63  1.46 NS
WBC’s (10/mm3) 8.7  3.93 8.0  3.52 NS
Bilirubin (mg/dl) 8.3  6.24 8.08  5.49 NS
Albumin (mg/dl) 2.91  0.45 2.77  0.32 NS
Creatinine (mg/dl) 1.14  0.42 1.21  0.46 NSup through the mesocolon, which was anastomosed in an end to
side fashion to the pancreatic remnant. A separate Roux loop was
fashioned for the hepaticojejunal anastomosis by dividing the je-
junum about 60 cm beyond the pancreatic anastomosis. This was
anastomosed end to side to the hepatic duct. The gastrojejunal
anastomosis was performed 25 cm downstream to the hep-
aticojejunostomy. The PJ loop was then sutured to the main loop
(Fig. 2). Two soft closed suction drains (16 French, ROMOVAC,
India) were placed, one closed to the pancreaticojejunal anasto-
mosis and other in the right subhepatic space. Pancreatic drain ﬂuid
amylase was measured on alternate days in the postoperative pe-
riod. In the absence of a pancreatic ﬁstula, the pancreatic drainwas
removed on Day 21. All patients received H2 receptor blocker
prophylaxis during the postoperative course.
The primary outcome assessed was the presence or absence of
a pancreatic ﬁstula, demonstrated clinically, radiologically or at
reoperation. Other features evaluated included differences in op-
erative times, blood loss and requirements, postoperative compli-
cations and length of hospital stay. Pancreatic ﬁstula was deﬁned as
an amylase rich (grater than three times serum amylase) drain
output of greater than 50 ml per day lasting beyond 7 days. Biliary
ﬁstulawas deﬁned as high output drainage ﬂuid with high bilirubin
level present for more than 7 days. Delayed gastric emptying was
deﬁned as the need for nasogastric tube drainage for more thanFig. 2. Isolated Roux-N-Y pancreaticojejunostomy.
Table 3
Intraoperative details (n ¼ 111) showing number and percentage andmean standard
deviation
Single loop
(n ¼ 51)
Isolated loop
(n ¼ 60)
p-value
Pancreaticoduodenectomy
Whipples 42 60
PPPD 9
Operative time (h) mean 6.07  1.12 7.25  1.14 0.021
Blood loss (ml) 656  180 611  151 NS
Blood transfusion (units) (mean) 2.25  0.84 2.62  0.69 0.014
Pancreatic texture
Hard 20 (39%) 14 (23%)
Soft 31 (61%) 46 (77%) NS
Pancreatic duct diameter
<3 mm 24 (47%) 21 (35%)
>3 mm 27 (53%) 39 (65%) NS
Table 4
Morbidity and mortality data (n ¼ 111) showing number and percentage with mean
standard deviation
Single loop
(n ¼ 51)
Isolated loop
(n ¼ 60)
p-value
Wound infection 15 (29%) 17 (28%) NS
Delayed gastric emptying 6 (12%) 12 (20%) NS
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after 10 days of surgery. Postoperative bleeding was deﬁned as
need of more than 2 units of blood transfusion after 24 h of surgery
or need for reoperation to control bleeding. Operative mortality
was deﬁned as death during the same admission or with in 30 days
of surgery.
2.2. Statistical analysis
Comparison of data between the two groups was done using the
Student’s t-tests for continuous variables and the Chi square test or
Fischer’s exact test as appropriate for categorical variables. P values
less than 0.05 were considered signiﬁcant. All statistical analysis
was performed using the SPSS (version 10.0) package.
3. Results
3.1. Study population
A total of 111 patients underwent pancreaticoduodenectomy, 51
of whom had a conventional single loop pancreaticojejunal re-
construction, while the remainder 60 patients received a Roux loop
PJ reconstruction. No differences were observed between the two
groups as regards clinical data and preoperative investigations
(Table 1). The indications for pancreaticoduodenectomy did not
differ signiﬁcantly between the two groups (Table 2).
3.2. Operative variables
The mean duration of surgery was signiﬁcantly longer in the
group that underwent isolated Roux loop reconstruction
(p ¼ 0.021). The total number of units of blood transfused was
greater in the isolated Roux loop group (p ¼ 0.014) (Table 3). There
was no signiﬁcant difference in the degree of blood loss, ratio of
pancreatic duct diameter (less than or more than 3 mm) and pan-
creatic parenchymal consistency (soft or hard).
3.3. Postoperative outcome
Overall, morbidity occurred in 29 (48%) patients of the isolated
Roux loop PJ group and 23 (45%) patients among the conventional
single loop PJ group (Table 4).
Wound infectionwas themost common complication seen in 32
(28.8%) patients, followed by pulmonary complications in 26
(23.4%) patients. Intra abdominal abscess was the most common
major complication, observed in 19 (17.1%) patients, followed by
delayed gastric emptying in 18 (16.2%), cholangitis in 10 (9%),
bleeding in 10 (9%) and leak from the hepaticojejunostomy in nine
(8.1%) patients. No signiﬁcant difference in the occurrence of these
complications was observed between the two groups. But all these
complications were more common in those patients who de-
veloped pancreatic ﬁstula.
Pancreatic ﬁstula was observed in 12 patients (10.8%). Six in the
Roux loop PJ (10%) and six in the conventional single loop PJ (12%)
(p ¼ 0.52). In the Roux loop PJ group three patients were managedTable 2
Pathologic diagnosis of patients among both groups (n ¼ 111) showing number and
percentage
Pathology Single loop (n ¼ 51) Isolated loop (n ¼ 60)
Pancreatic cancer 21 (41%) 28 (47%)
Ampullary cancer 18 (35%) 16 (27%)
Cholangiocarcinoma 4 (8%) 9 (15%)
Duodenal cancer 5 (10%) 5 (8%)
Chronic pancreatitis 3 (6%) 2 (3%)conservatively with out reoperation. One patient required multiple
radiological guided drainage for abdominal collections. Two pa-
tients required reoperation because of associated abscess and
sepsis. In the single loop PJ group four patients were managed
conservatively for low out put ﬁstula. Two patients underwent
surgery for intra-abdominal collection and sepsis.
There was no signiﬁcant difference in the duration of hospital
stay between the two groups (p ¼ 0.89).3.4. Mortality
Nine (8.1%) patients died with ﬁve deaths occurring in the iso-
lated Roux loop PJ group and four in the single loop PJ group (8.3%
vs 7.8%). Analysis of the cause of death showed ﬁve patients died of
surgical complications. Out of these ﬁve patients, four patients had
pancreaticojejunostomy leak. So pancreaticojejunostomy leak had
a direct bearing on the mortality rate. In the Roux loop PJ group
two patients had PJ leak and was operated for and both of them
died in the postoperative period. Three patients died of associ-
ated cardio-pulmonary and sepsis related causes. All three pa-
tients had insulin dependent diabetes mellitus and history of
pre-existing cardiac disease. In the single loop PJ group two pa-
tients had PJ leak and died. One patient had hepaticojejunostomy
leak with intra-abdominal bleeding for which re-exploration was
done, but ultimately died. One patient died of cardio-pulmonary
events. This patient was a patient of unstable angina with chronic
obstructive pulmonary airway disease, which got aggravated af-
ter surgery.Pulmonary complications 11 (22%) 15 (25%) NS
Pancreatic ﬁstula 6 (12%) 6 (10%) NS
Hepaticojejunostomy leak 2 (4%) 7 (12%) NS
Gastrojejunostomy leak 1 (2%) 1 (2%) NS
Cholangitis 4 (8%) 6 (10%) NS
Intra-abdominal abscess 6 (12%) 13 (22%) NS
Bleeding 3 (6%) 7 (12%) NS
Cardiac complications 4 (8%) 6 (10%) NS
Urinary tract infection 1 (2%) 3 (5%) NS
No. of pts. with complications 23 (45%) 29 (48%) NS
Postoperative hospital stay (days) 17.50  6.02 17.75  6.30 NS
Mortality 4 (7.8%) 5 (8.3%) NS
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Pancreaticoduodenectomy has evolved over a period of many
decades and has become a safe procedure in specialist centers with
a mortality of 1–5%.1–7 But still the rate of pancreaticojejunal leak
and ﬁstula is quite signiﬁcant, occurring in 5–25% of operated pa-
tients.1–7 The deﬁnition of pancreatic ﬁstula is also not very clear.
Recently the International Study Group on Pancreatic Fistula
(ISGPF) leak group deﬁned pancreatic ﬁstula as drain out put for
more than 3 days and amylase level of more than three times
normal.15 Using this ISGPF deﬁnition the pancreatic leak rate
was found in 26.7% in 1507 patients who underwent pan-
creaticoduodenectomy. But we used another criterion to deﬁne
pancreatic ﬁstula. Pancreatic ﬁstula was deﬁned as an amylase rich
(greater than three times serum amylase) drain output of greater
than 50 ml per day lasting beyond 7 days. Pancreatic ﬁstula is as-
sociated with a signiﬁcant morbidity and mortality rate. A pan-
creaticojejunal anastomosis is among the most widely used means
of managing the pancreatic remnant. To reduce the incidence of
pancreatic leak, a number of variations involving the method of
pancreaticojejunostomy have been reported. These include, among
others, use of end-to-end pancreaticojejunal invagination,16 ends to
side duct to mucosa anastomosis,10,14,17 and pancreatic duct stent
placement.18 Many other methods of managing the pancreatic
remnant after PD have been mentioned in the literature.19–24
The use of an isolated Roux loop to the pancreatic remnant was
ﬁrst reported in 1976 by Machado et al.8 In their series of 15 pa-
tients of pancreaticoduodenectomy, where they performed isolated
Roux loop PJ, two patients developed pancreatic ﬁstula but both of
them survived. Funovics et al.9 reported the results of 131 patients
where they compared four methods of reconstruction after pan-
creaticoduodenectomy. The use of two separate intestinal loops for
reconstruction of the pancreas and biliary tract offered the best
results.
Kingsnorth10 reported his results of 52 patients of PD where he
used the isolated Roux loop PJ without any pancreatic leak and
excellent outcome. Khan et al.14 also reported 41 patients with PD
where they constructed isolated Roux loop PJ without any leak or
ﬁstula. In all these studies, the emphasis was on the low incidence of
pancreatic ﬁstula and even if there was a ﬁstula, a low incidence of
ﬁstula related mortality. Recently Wayne et al.25 reported 0% PJ
anastomotic leak, delayed gastric emptying andmortality in a small
group of 13 patients who underwent undivided Roux-en-Y PJ fol-
lowing whipple procedure. The main advantage was complete ab-
sence of delayed gastric emptying. Sutton et al.26 also reported 0% PJ
anastomotic leak after isolated Roux-en-Y reconstruction in a series
of 61 patients. Ma et al.27 also reported a series of 26 patients with
isolated Roux-en-Y PJ anastomosis without any leak and mortality.
Many surgeon argue that pancreaticogastrostomy after pan-
creatic head resection is a safer option than pancreatico-
jejunostomy because of anatomical and physiological reasons. In
a recent meta-analysis of panacreaticogastrostomy versus pan-
creaticojejunostomy after pancreaticoduodenectomy concluded
that pancreaticogastrostomy is a safer means of pancreatic re-
construction after pancreaticoduodenectomy.2 However much of
the evidence came from observational cohort study data and there
was no conclusive data to show that pancreaticogastrostomy
was superior to pancreaticojejunostomy. In our institute we
exclusively do pancreaticojejunostomy reconstruction after
pancreaticoduodenectomy.
The advantages of an isolated Roux loop PJ include prevention of
mixing of both bile and intestinal content and pancreatic juice by
the use of a long isolated Roux-loop reconstruction.8–10 Moreover
bile reﬂux is a well recognized factor associated with the induction
of acute pancreatitis, particularly when associated with sepsis. The
less activation of pancreatic secretion by bile, affords better andfaster healing in the event of an anastomotic dehiscence and a ﬁs-
tula site distant to that of other anastomosis may provide better
collagen support at the site of anastomosis for faster healing. In our
series the study population, presentation, pathology, operative
variables were similar in the two groups. In both the group duct to
mucosa anastomosis was done. So the two groups were comparable
in all the aspects. In our study the incidence of pancreatic ﬁstula
was 10.8% overall, being 12% following single loop reconstruction
and 10% after Roux loop PJ.
Our studyhas not found any signiﬁcant difference in the incidence
of pancreatic ﬁstula following either method of reconstruction,
keeping relatively similar factors such as pancreatic duct diameter,
parenchymal consistency, duct to mucosa anastomosis, use of
pancreatic stents, primary pathology and clinical proﬁles, which
might account for an increased incidence of the same.
The leakage from the hepaticojejunal anastomosis was more in
the group undergoing an isolated Roux loop PJ 7 (12%) compared to
single loop PJ 2 (4%), although this difference was not statistically
signiﬁcant. The incidence of biliary ﬁstula rate is deﬁnitely high but
no cause could be pinpointed for this particular problem. Delayed
gastric emptying was observed in 16.2% of patients and was not
signiﬁcantly different between the two groups. The occurrence of
this complication was within the quoted range for both conven-
tional and Roux loop PJ reconstruction.9,17,20,28
Nine (8.1%) patients died with ﬁve deaths occurring in the iso-
lated Roux loop PJ group and four in the single loop PJ group (8.3%
vs 7.8%). Analysis of the cause of death showed ﬁve patients died of
surgical complications. In the Roux loop PJ group two patients had
PJ leak and was operated for and both of them died in the post-
operative period. In the single loop PJ group two patients had PJ
leak and died. In both the group PJ leak had lead on to death in two
patients each. The mortality rate is slightly more than what is
reported from high volume dedicated center, but still in the ac-
ceptable range. The cause for this increase mortality rate may be
because of surgical as well as associated medical comorbidities. We
lost seven patients in the early part of the study period and only
two patients died in the last 50 procedures. So isolated Roux loop PJ
had not provided any advantage in terms of anastomotic leakage
and associated mortality over the single loop PJ. This was in con-
trary to the published reports of less incidence of pancreatic ﬁstula
rate and ﬁstula related mortality.8, 9,10,13,14
Possible disadvantages of an isolated Roux loop PJ are an in-
creased operative time and the presence of an additional anasto-
mosis. In our study use of a isolated Roux loop PJ reconstruction
was associated with signiﬁcantly prolonged operative times (op-
erative time of 7 h as compared to 6.5 h) and more intraoperative
blood loss and transfusion.
In the continuing search for a means to reduce the incidence of
pancreatic leaks, our review does not demonstrate any signiﬁcant
beneﬁt associatedwith the Roux loop pancreaticojejunal method of
reconstruction compared to that of conventional single loop pan-
creaticojejunal reconstruction after pancreaticoduodenectomy.Conﬂict of interest
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